Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2017 Aug 13;2017:6761452. doi: 10.1155/2017/6761452

Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”

Gamal A Shazly 1,2,*
PMCID: PMC5572084  PMID: 28884127

In the article titled “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment” [1], there was an error in Acknowledgments, which should be corrected as follows.

The author acknowledges the Deanship of Scientific Research at King Saud University for funding this work through the Research Group Project no. RGP-VPP-139. The author also extends gratitude to Dr. Amany Z. Mahmoud, Department of Pharmaceutics, College of Pharmacy, King Saud University, for her technical support in the antibacterial activity study.

References

  • 1.Shazly G. A. Ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment. BioMed Research International. 2017;2017:9. doi: 10.1155/2017/2120734.2120734 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES